Health Care PRICE Transparency Act
HB267, titled the Health Care PRICE Transparency Act, would expand federal health care price-disclosure requirements for hospitals and health insurers. For hospitals, it would require standard charges to be posted in plain language, free of charge, without subscription, and in a consumer-friendly machine-readable format. The bill also requires hospitals to disclose a broader set of pricing data, including gross charges, payer-specific negotiated rates, minimum and maximum negotiated charges, discounted cash prices, and billing/coding identifiers, and to make this information available for at least 300 shoppable services when possible.
The bill also strengthens transparency rules for health coverage under the Affordable Care Act. It would require insurers and exchanges to provide more detailed cost-sharing information, including in-network rates, out-of-network allowed amounts, historical net prices for prescription drugs, accumulated amounts toward deductibles and out-of-pocket limits, and notices about balance billing and coverage limitations. It further extends these disclosure requirements beyond qualified health plans to group health plans, including self-insured and fully insured plans, and health insurance coverage more generally.
If enacted, the bill would amend the Public Health Service Act and the Affordable Care Act to impose more detailed federal transparency obligations on hospitals, insurers, and health plans. It would likely increase compliance duties for hospitals, issuers, exchanges, third-party administrators, and related entities by requiring more standardized public posting, searchable online tools, paper disclosures on request, and additional definitions governing how pricing and cost-sharing information is calculated and presented. The bill also adds enforcement by authorizing civil monetary penalties of up to $300 per day for hospitals that fail to comply after corrective action opportunities.
Based on the bill text and the absence of recorded committee debate or votes, the measure appears to be framed as a consumer-protection and market-transparency proposal. Its stated purpose is to make health care pricing more understandable and accessible before care is received, suggesting a generally pro-transparency, pro-consumer policy approach. No formal vote history or transcript record is provided, so there is no documented legislative sentiment beyond the bill’s design and title.
The main likely points of contention are the scope and administrative burden of the new disclosure requirements. Hospitals may object to the expanded list of required data elements, the 300-shoppable-service benchmark, and the penalty structure, while insurers and plans may raise concerns about the complexity of real-time cost-sharing tools, paper disclosure timelines, and the requirement to disclose historical net prices and out-of-network payment information. Another possible issue is whether the bill’s broad application to group health plans and self-insured coverage could create compliance challenges or overlap with existing federal transparency rules.